Critically Appraised Topic
Topic:Does topical estrogen decrease recurrent UTIs in postmenopausal women?
Case Scenario:
67 yo female with three episodes of symptomatic lower UTI (frequency, dysuria, urine culture with >10,000 sensitive E. coli) wondering if there is "anything else" we can offer her.
Clinical Bottom Lines:
1. Topical estrogen decreases UTIs in postmenopausal women with recurrent UTIs.
2. Due to side effects (itching and burning) 28% of treated and 17% of placebo patients dropped out of the study.
Evidence:
Double-blinded, randomized, placebo-controlled trial of 93 postmenopausal women with a history of recurrent UTIs using placebo vs 0.5 mg Estriol intravaginal cream
|
Endpoint |
Estriol |
Placebo |
RRR |
ARR |
NNT |
|
UTI's per pt.-yr. |
0.5 |
5.9 |
91.5% |
5.4 |
0.18 |
Comments:
1. Estrogen was unmeasurable in the serum after 24 h after topical application
2. Cost of topical estrogen for 6 months treatment:
|
UNC |
Eckerd |
Revco |
Kerr |
|
$56.34 |
$119.07 |
$137.97 |
$131.97 |
Cost of 3 days of antimicrobials for 3 episodes of uncomplicated UTI (6 month risk)
|
UNC |
Eckerd |
Revco |
Kerr |
|
|
Septra |
$15.72 |
14.97 |
11.97 |
20.97 |
|
Cipro 500 |
$49.02 |
79.27 |
79.77 |
84.87 |
References:
R. Raz and W. Stamm. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. NEJM 1993;329:753-6.
Key Words:
urinary tract infection, estrogen